India could move directly towards preventive and natural-looking aesthetic treatments, according to Korean pharmaceutical and aesthetics company JETEMA. Pablo Kim, Executive Director, Global Business Department at JETEMA, said India presents significant potential for the company. JETEMA operates across more than 70 countries and is currently studying the Indian market before establishing a formal presence. Kim said India differs significantly from ...